Management of incidental pituitary microadenomas: A cost-effectiveness analysis

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 11, 1997, Pages 3625-3632

  King Jr , Joseph T ^a,b,c   Justice, Amy C ^a,c   Aron, David C ^a,c,d  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^d LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; DEXAMETHASONE; PROLACTIN; SOMATOMEDIN C;

ARTICLE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; FOLLOW UP; HUMAN; HYPOPHYSIS ADENOMA; MEDICAL DECISION MAKING; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; STEREOTAXIC SURGERY; SURVIVAL; TRANSSPHENOIDAL SURGERY; TREATMENT OUTCOME; TUMOR DIAGNOSIS;

EID: 0030691836     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.11.3625     Document Type: Article

References (74)

1. Hardy J. 1973 Transsphenoidal surgery of hypersecreting pituitary tumors. In: Kohler PO, Ross GT, eds. Diagnosis and treatment of pituitary tumors. Amsterdam: Excerpta Medica; 179-194.
2. Molitch ME, Russell EJ. 1990 The pituitary "incidentaloma." Ann Intern Med 112:925-931.
3. Scheithauer BW, Sano T, Kovacs KT, Young WFJ, Ryan N, Randall RV. 1990 The pituitary gland in pregnancy: a clinicopathologic and immunohistochemical study of 69 cases. Mayo Clin Proc. 65:461-474.
4. Marin F, Kovacs KT, Scheithauer BW, Young WFJ. 1992 The pituitary gland in patients with breast carcinoma: a histologic and immunocytochemical study of 125 cases. Mayo Clin Proc. 67:949-956.
5. Sano T, Kovacs KT, Scheithauer BW, Young WFJ. 1993 Aging and the human pituitary gland. Mayo Clin Proc. 68:971-977.
6. Scheithauer BW, Kovacs KT, Young WFJ, Randall RV. 1992 The pituitary gland in hyperthyroidism. Mayo Clin Proc. 67:22-26.
7. Hall WA, Luciano MG, Doppman JL, Patronas NJ, Oldfield EH. 1994 Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann Intern Med. 120:817-820.
8. Aron DC. 1995 Hormonal screening in the patient with an incidentally discovered piruitary mass: current practice and factors in clinical decision making. Endocrinologist. 5:357-363.
9. Klibanski A, Zervas NT. 1991 Diagnosis and management of hormone-secreting pituitary adenomas. N Engl J Med. 324:822-831.
10. Aron DC, Ross NS. 1990 Pituitary "incidentaloma." Ann Intern Med. 113:558-559.
11. Molitch ME. 1995 Prolactinoma. In: Melmed S, ed. The pituitary. Cambridge: Blackwell; 443-477.
12. Gold EG. 1981 Epidemiology of pituitary adenomas. Epidemiol Rev. 3:163-183.
13. Ambrosi B, Faglia G, Multicenter Pituitary Tumor Study Group. 1991 Epidemiology of pituitary tumors. In: Faglia G, Beck-Peccoz P, Ambrosi B, Travaglini P, Spada A, eds. Pituitary adenomas: new trends in basic and clinical research. New York: Elsevier; 159-168.
14. Radhakrishnan K, Mokri B, Parisi JE, O'Fallon WM, Sunku J, Kurland LT. 1995 The trends in incidence of primary brain tumors in the population of Rochester, Minnesota. Ann Neurol. 37:67-73.
15. Miyai K, Ichihara K, Kondo K, Mori S. 1986 Asymptomatic hyperprolactinaemia and prolactinoma in the general population: mass screening by paired assays of serum prolactin. Clin Endocrinol (Oxf). 25:549-554.
16. Shy KK, McTiernan AM, Daling JR, Weiss NS. 1983 Oral contraceptive use and the occurrence of pituitary prolactinoma. JAMA. 249:2204-2207.
17. Annegers JF, Coulam CB, Abboud CF, Laws ERJ, Kurland LT. 1978 Pituitary adenoma in Olmstead County, Minnesota, 1935-1977: a report of an increasing incidence of diagnosis in women of childbearing age. Mayo Clin Proc. 53:641-643.
18. Alexander L, Appleton D, Hall R, Ross WM, Wilkinson R. 1980 Epidemiology of acromegaly in the Newcastle region. Clin Endocrinol (Oxf). 12:71-79.
19. Bengtsson BA, Eden S, Ernest I, et al. 1988 Epidemiology and long-term survival in acromegaly. Acta Med Scand. 223:327-335.
20. Extabe J, Vazquez JA. 1994 Morbidity and mortality in Cushing's disease: an epidemiological approach. Clin Endocrinol (Oxf). 40:479-484.
21. Oppenheim DS, Kana AR, Sangha JS, Klibanski A. 1990 Prevalence of α-subunit hypersecretion in patients with pituitary tumors: clinically non-functioning and somatotroph adenomas. J Clin Endocrinol Metab. 70:859-864.
22. Daneshdoost L, Gennarelli TA, Bashey HM, et al. 1991 Recognition of gonadotroph adenomas in women. N Engl J Med. 324:589-594.
23. Mindermann T, Wilson CB. 1993 Thyrotropin-producing pituitary adenomas. J Neurosurg. 79:521-527.
24. Samuels MH, Ridgway EC. 1995 Glycoprotein-secreting pituitary adenomas. Clin Endocrinol Metab. 9:337-358.
25. Reincke MR, Allolio B, Saeger W, Menzel J, Winkelmann W. 1990 The 'incidentaloma' of the pituitary gland. Is neurosurgery required? JAMA. 263:2772-2776.
26. Donovan LE, Corenblum B. 1995 The natural history of the pituitary incidentaloma. Arch Intern Med. 155:181-183.
27. Aron DC, Tyrrell JB, Wilson CB. 1995 Pituitary tumors: current concepts in diagnosis and management. West J Med. 162:340-352.
28. Vance ML, Thorner MO. 1987 Prolactinomas. Endocrinol Clin North Am. 16:731-753.
29. Randall RV, Laws ERJ, Abboud CF, Ebersold MJ, Kao PC, Scheithauer BW. 1983 Transsphenoidal microsurgical treatment of prolactin-producing pituitary adenomas. Results in 100 patients. Mayo Clin Proc. 58:108-121.
30. Sox HC, Blatt MA, Higgins MC, Marton KI. 1988 Measuring the accuracy of clinical data. In: Medical Decision Making. Boston: Butterworth-Heinemann; 103-145.
31. Melmed S. 1990 Acromegaly. N Engl J Med. 322:966-976.
32. Chang-DeMoranville BM, Jackson MD. 1992 Diagnosis and endocrine testing in acromegaly. Endocrinol Clin North Am. 21:649-668.
33. Barkan AL. 1989 Acromegaly. Endocrinol Clin North Am. 18:277-310.
34. LeRoith D, Clemmons D, Nissley P, Rechler MM. 1992 NIH conference. Insulin-like growth factors in health and disease. Ann Intern Med. 116:854-862.
35. Ransohoff DF, Feinstein AR. 1978 Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. N Engl J Med. 299:926-930.
36. Findling JW, Doppman JL. 1994 Biochemical and radiologic diagnosis of Cushing's syndrome. Endocrinol Clin North Am. 23:511-537.
37. Pituitary Adenoma Study Group. 1982 Variation in assessing sella turcica tomograms for pituitary microadenomas. Obstet Gynecol. 60:700-704.
38. Taylor CR, Jaffe CC. 1983 Methodological problems in clinical radiology research: pituitary microadenoma detection as a paradigm. Radiology. 147:279-283.
39. Turski PA, Newton TH, Horten BH. 1981 Sellar contour: anatomic polytomographic correlation. Am J Roentgenol. 137:213-216.
40. Burrows GN, Wortzman G, Rewcastle NB, Holgate RC, Kovacs K. 1981 Microadenomas of the pituitary and abnormal sellar tomograms in an unslected autopsy series. N Engl J Med. 304:156-158.
41. Chambers EF, Turski PA, LaMasters D, Newton TH. 1982 Regions of low density in the contrast-enhanced pituitary gland: normal and pathologic processes. Radiology. 144:109-113.
42. Davis PC, Hoffman Jr JC, Tindall GT, Braun IF. 1985 CT-surgical correlation in pituitary adenomas: evaluation in 113 patients. Am J Roentgenol. 6:711-716.
43. Johnson MR, Hoare RD, Cox T, et al. 1992 The evaluation of patients with suspected pituitary microadenoma: computer tomography compared to magnetic resonance imaging. Clin Endocrinol (Oxf). 36:335-338.
44. Webb SM, Ruscalleda J, Schwarzstein D, et al. 1992 Computerized tomography versus magnetic resonance imaging: a comparative study in hypothalamic-pituitary and parasellar pathology. Clin Endocrinol (Oxf). 36:459-465.
45. Elster AD. 1993 Modern imaging of the pituitary. Radiology. 187:1-14.
46. Chong BW, Kucharaczyk W, Singer W, George S. 1994 Pituitary gland MR: a comparative study of healthy volunteers and patients with microadenomas. Am J Neuroradiol. 15:675-679.
47. Laws Jr ER, Thapar K. 1995 Surgical management of pituitary adenomas. Clin Endocrinol Metab. 9:391-405.
48. Laws Jr ER. 1996 Pituitary surgery. Endocrinol Clin North Am. 16:647-665.
49. Harlberg FE, Sheline GE. 1987 Radiotherapy of pituitary tumors. Endocrinol Clin North Am. 16:667-684.
50. Rosner R, Kind K. 1978 A scale of valuations of states of illnesses: is there a social consensus? Int J Epidemiol. 7:347-358.
51. Torrance GW. 1987 Utility approach to measuring health-related quality of life. J Chron Dis. 40:593-600.
52. Torrance GW, Feeny D. 1989 Utilities and quality-adjusted life years. Int J Technol Assess Health Care. 5:559-575.
53. Ahlsiö B, Britton M, Murray V, Theorell T. 1984 Disablement and quality of life after stroke. Stroke. 15:886-890.
54. Anonymous. 1994. Fed Regul. 59:63410-63635.
55. Anonymous. 1995 Table 33. Annual data: Consumer Price Index, U.S. city average, all items and major groups. Monthly Labor Rev. 118:104
56. Anonymous. 1995 Drug topics red book. Montvale: Medical Economics Co.
57. Drummond MF, Stoddard GL, Torrance GW. 1987 Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press.
58. Sox HC, Blatt MA, Higgins MC, Marton KI. 1988 Medical decision making. Stoneham: Butterworth-Heineman.
59. Krahn M, Gafni A. 1993 Discounting in the economic evaluation of health care interventions. Med Care. 31:403-418.
60. Chapman GB, Elstein AS. 1995. Valuing the future: temporal discounting of health and money. Med Decision Making. 15:373-386.
61. Beck JR, Pauker SG. 1983 The Markov process in medical decision making. Med Decision Making. 3:419-458.
62. Sonnenberg FA, Beck JR. 1993 Markov models in medical decision making: a practical guide. Med Decision Making. 16:322-338.
63. Woolf SH, Kamerow DB. 1990 Testing for uncommon conditions. The heroic search for positive results. Arch Intern Med. 150:2451-2458.
64. Nord E. 1993 Toward quality assurance in QALY calculation. Int J Technol Assess Health Care. 9:37-45.
65. Stiggelbout AM, Eijkenmans MJC, Kiebert GM, Kievit J, Leer JH, DeHaes HJCJM. 1996 The 'utility' of the visual analog scale in medical decision making and tecnnology assessment: is it an alternative to the time trade-off. Int J Technol Assess Health Care. 12:291-298.
66. King Jr JT, Glick HA, Mason TJ, Flamm ES. 1995 Elective surgery for asymptomatic, unruptured, intracranial aneurysms: a cost-effectiveness analysis. J Neurosurg. 83:403-412.
67. Sullivan KE, Herbert PC, Logan J, O'Connor AM, McNeely PD. 1996 What do physicians tell patients with end-stage COPD about intubation and mechanical ventilation? Chest. 109:258-264.
68. Kayser-Jones J. 1995 Decision making in the treatment of acute illness in nursing homes: framing the decision problem, treatment plan, and outcome. Med Anthropol Q. 9:236-256.
69. Jacoby A, Baker G, Chadwick D, Johnson A. 193 The impact of counseling with a practical statistical model on patient's decision-making about treatment for epilepsy: findings from a pilot study. Epilepsy Res. 16:207-214.
70. Miller DK, Coe RM, Hyers TM. 1992 Achieving consensus on withdrawing or withholding care for critically ill patients. J Gen Intern Med. 7:475-480.
71. Black WC, Welch HG. 1993 Advances in diagnostic imaging and overestimation of disease prevalence and the benefits of therapy. N Engl J Med. 328:1237-1243.
72. Mold JW, Stein HF. 1986 The cascade effect in the clinical care of patients. N Engl J Med. 314:512-514.
73. Haddix AC, Teutsch SM, Shaffer PA, Dunet DO, eds. 1996 Prevention effectiveness: a guide to decision analysis and economic evaluation. New York: Oxford University Press.
74. Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. 1996 Cost-effectiveness in health and medicine. New York: Oxford University Press.